Apellis Pharmaceuticals Inc (APLS) Options

how on earth do you get any numbers for FCEL in the next year that even approach one quarter of Blooms revenues.

there are 36 modules for Korea and then only 10 more for the whole of 2025, 2026 and 2027

at $300k per module that isn't much revenue from "Service" (lets

THERE'S NO VOLUME BECAUSE IT'S NOTHING BUT A POS SCAM RUN BY LYING GRIFTERS!!!

Oh hey, it's the NVDA guy. How's that going? 😂

Has “Fool Production” started?

Bottom line
Anyone buying at this price is buying a minimum 2X bagger within 90 days

GLTA

My favorites are the ones that draw lines on charts. Draw some lines on a blank chart and show me your lines before the chart draws itself. If they match....then I'll be impressed.

You have to bring the beer....

Damn right!

Searay, it is what it is, and that is this is a publicly traded stock, for a company trying to compete for it's share of the multi-billion dollar House-wrap industry. The superior product of the Insultex evacuated cells, also makes them a partial player in the Insulation's billion dollar industry. T

The only reality that matters - erhe is closer to zero than to dollars. As long as that is true, dickran is a proven liar.

Just think, for every $100 gullible fools paid for made up, lying, gus bus, dickran "insider info", 1 million erhe shares could have been purchased. But volume r

A conversation with Gemini

Summarize Waiting for Godot

"Waiting for Godot" is a play by Samuel Beckett that explores themes of existentialism, the absurdity of human existence, and the search for meaning. Here's a summary:

The Premise:
The play cen

More like deader

Up on a day like today!?
Talk about floor support
Wait until this temporary tariff distraction is over

GLTA

And more:

https://bsky.app/profile/atrupar.com/post/3lk4snxpwmk2c

Steady T, it's true that the UK accepted the tiny capability at Sawston for meeting initial commercial requirements.
Nonsense.

The MHRA has said that Advent follows GMP for commercial manufacturing in general, but nothing about any specific product which is a different approval

$ETHU got some $2s. Dead-cat or good-entry?

Who tf knows...

GLTA!

I've been following this closely enough to say with 100% certainty there was no such press release.

There's a play-by-play overview on another board that details everything that's happened with SFLM since 2022. Link below...

https://investorshangout.com/post/view?id=669

Down she goes another-7%

https://www.myflcourtaccess.com/nefdocuments/document.nefdd?nai=4gwdnNOTUfl9jGxhZmibCTuisAUMYVsV&ds=1

Potential is nice, actual delivery way better

Will you stop lying and posting on this board if the revenue in the first year is less than $15M? It won’t be a supply problem. It will be a demand issue due to no reimbursement support.

Eden will not be approved for commerical production for another 18 months. Take that to the bank!

FEIM...Will report earnings Thurs AMC...Frequency Electronics Announces Third Quarter Fiscal 2025 Financial Results Conference Call: Thursday, March 13, 2025, at 4:30 PM ET
I still hold some shares.
https://finance.yahoo.com/news/frequency-electronics-announces-third-quarter-202600184.

Gold Nears Key Resistance, but Direction Remains Uncertain
By: Bruce Powers | March 11, 2025

• Gold remains firm above $2,912, signaling short-term strength, but a decisive breakout above $2,930 is needed to confirm a continuation higher.

Despite the potenti

Why wouldn't they be successful,

22 years and 13 business models, all failures.

But you are half right, Reggie has a brillant mind.

That's some $dollar-volume for sure!
What about today?